Market Research Industry Today

Artificial Heart-Lung Machine Market Size, Share, Analysis, Trends, Report 2023-2028

An artificial heart-lung machine, also known as a cardiopulmonary bypass (CPB) or oxygenator pump, is used during coronary artery bypass, heart and lung transplants, and other cardiac surgeries.
Published 11 December 2023

IMARC Group’s latest report, titled “Artificial Heart-Lung Machine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on Artificial Heart-Lung Machine Market Outlook. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global artificial heart-lung machine market size reached US$ 282.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 351.6 Million by 2028, exhibiting a growth rate (CAGR) of 3.6% during 2023-2028.

An artificial heart-lung machine is a medical device designed to temporarily take over the functions of the heart and lungs during cardiac surgery. It serves a crucial role in supporting circulation and oxygenation of blood when the heart needs to be stopped for surgical procedures, such as open-heart surgery or heart transplantations. The machine typically consists of a pump to circulate blood, an oxygenator to add oxygen and remove carbon dioxide, and tubing to connect the patient to the machine. During the procedure, blood is diverted from the patient's body to the artificial heart-lung machine, allowing surgeons to work on the heart while maintaining oxygenated blood flow throughout the body. This technology enables intricate cardiac surgeries by providing a controlled environment and allowing medical professionals to perform complex procedures with the assurance of maintaining oxygen supply and blood circulation.

Get a Sample Copy of this Report: https://www.imarcgroup.com/artificial-heart-lung-machine-market/requestsample

Market Trends:

The global market is majorly driven by the increasing prevalence of cardiovascular diseases and the growing demand for complex cardiac surgeries. As the global population ages and lifestyles evolve, there is a rise in cardiac conditions necessitating surgical interventions. Artificial heart-lung machines play a pivotal role in these surgeries, providing a temporary support system to ensure oxygenation and circulation. At the same time, the heart is stopped for procedures like bypass surgeries or valve replacements. Besides, rapid technological advancements are propelling the market forward. Continuous innovations in materials, design, and components of artificial heart-lung machines enhance their efficiency, safety, and overall performance. Miniaturization and integration of smart technologies have led to more compact and user-friendly machines, making them more accessible to a broader range of healthcare facilities. These technological advancements not only improve the functionality of the machines but also contribute to better patient outcomes and shorter recovery times, catalyzing the market.

Moreover, the expanding field of organ transplantation is a significant driver for the artificial heart-lung machine market. Heart transplants and other intricate cardiac procedures often require the use of these machines to support the patient's circulatory and respiratory functions during surgery. The increasing prevalence of organ failure and the growing acceptance of transplantation as a viable treatment option fuel the demand for advanced heart-lung machines. Besides, the rising awareness and investment in healthcare infrastructure globally contribute to market growth. Developing countries are witnessing an increase in healthcare spending, leading to the establishment of more advanced medical facilities equipped with state-of-the-art technologies, including artificial heart-lung machines. This trend is particularly noteworthy in regions where there is a growing focus on improving healthcare access and addressing the burden of cardiovascular diseases.

Additionally, the COVID-19 pandemic has underscored the importance of respiratory and cardiac support systems, boosting the demand for artificial heart-lung machines. The critical role these machines play in managing severe respiratory distress has become evident, leading to heightened recognition and investment in technologies that support vital organ functions during medical crises.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/artificial-heart-lung-machine-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Medtronic Inc
  • Sorin Group
  • MAQUET GmbH & Co. KG
  • Terumo Corporation
  • R. Bard Inc
  • Tianjin Medical
  • Edwards Lifesciences
  • Jarvik Heart
  • Braile Biomédica
  • SynCardia

Artificial Heart-Lung Machine Market Segmentation:

Our report has categorized the market based on region, type, application and end use industry.

Breakup by Type:

  • Single Roller Pump
  • Double Roller Pump

Breakup by Application:

  • Cardiac Surgeries
  • Lung Surgeries
  • Acute Respiratory Failure Treatment
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Browse Other Reports:

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Other Industry News

Ready to start publishing

Sign Up today!